Eli Lilly And reported $2.62B in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
ALKERMES ALKS:US $ 254.65M 27.91M
Amgen AMGN:US $ 5203M 1325M
AstraZeneca AZN:LN 395649.11M 43092.62M
Astrazeneca AZN:US $ 4817M 945M
Baxter International BAX:US $ 1852M 442M
Biogen BIIB:US $ 2646.6M 897.3M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Catalent CTLT:US $ 449M 337M
Coherus Biosciences CHRS:US $ 275.48M 50.2M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 646500M 450200M
Glaxosmithkline GSK:US $ 6465M 4502M
Horizon Pharma HZNP:US $ 1892.56M 249.43M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Lannett LCI:US $ 87.85M 18.25M
Medtronic MDT:US $ 2140M 1574M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NOVN:VX SF 3625M 10227M
Novartis NVS:US $ 3625M 10227M
Perrigo Ordinary Shares PRGO:US $ 485.3M 1480.2M
Phibro Animal Health PAHC:US $ 74.25M 3.5M
Prestige Brands PBH:US $ 35.87M 8.68M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Revance Therapeutics RVNC:US $ 69.42M 128.94M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
United Therapeutics UTHR:US $ 795.2M 18.1M
Zoetis ZTS:US $ 2648M 484M